Skip to content

Acute Changes in Cortical Activation during Activeankle Movement after Extracorporeal Shock WaveTherapy for Spasticity in Hemiplegic Legs of Stroke Patients: a Functional Near-infrared Spectroscopy Study

Acute Changes in Cortical Activation during Activeankle Movement after Extracorporeal Shock WaveTherapy for Spasticity in Hemiplegic Legs of Stroke Patients: a Functional Near-infrared Spectroscopy Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065522
Enrollment
Unknown
Registered
2022-11-08
Start date
2022-11-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spasticity in Hemiplegic Legs of Stroke Patients

Interventions

Trial group:A single extracorporeal shock wave was applied to the patient's hamstring, gastrocnemius, and soleus muscles
Control group:Sham stimulation was provided by playing the ESW treatment sound without turning the device on in contact with the skin.
Healthy people group:A single extracorporeal shock wave was applied to the patient's hamstring, gastrocnemius, and soleus muscles

Sponsors

Wuhan Wuchang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Age 20-80 years old; 2. patients with confirmed hemiplegic leg spasticity after stroke and stroke time > 3 months; 3. increased muscle tone of the affected lower limb (soleus MAS score = 1); 4. Brunnstrom score of hemiplegic lower limbs 3-5. Inclusion criteria of healthy volunteers: 1. age 20-80 years old; 2. No history of neurological disease or current treatment with acute or chronic medications affecting the central nervous system

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patients with severe cognitive impairment and mental illness; 2. Patients with coagulopathy and bleeding disorders; 3. Presence of thrombus in the treatment area; 4. Patients with severe arrhythmia; 5. Patients with severe hypertension and poor blood pressure control; 6. Patients with cardiac pacemaker; 7. Patients with malignant tumors; 8. Pregnant women; 9. Patients with sensory dysfunction; 10. Patients with acute attack of gout; 11. Patients with tendon and fascia rupture and severe injury.

Design outcomes

Primary

MeasureTime frame
Functional brain imaging with near-infrared spectroscopy monitored oxygen-hemoglobin concentrations in bilateral primary sensorimotor cortex;Modified Ashworth Scale (MAS);A-ROM?P-ROM;Brunnstrom Rating Scales;

Secondary

MeasureTime frame
Fugl-Meyer Assessment Lower limbs;mini-mental state examination;straight legraising test;

Countries

China

Contacts

Public ContactTangzhu Yang

Wuhan Wuchang Hospital

258582639@qq.com=86 18627071976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026